Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
In the next five years, the global consumption of Interventional Cardiology will maintain more than 3% annual growth rate, Industry is mainly concentrated in Europe, USA, Japan and China.
At present, Chinese market is mainly occupied by imported brands. The domestic enterprise technology still needs to develop.
As Chinese number of heart disease and cardiovascular disease people is increasing, Chinese Interventional Cardiology market is predicted to be growing fast.
Average industry gross margin is between 70% and 80%, that is to say, Interventional Cardiology Project is a good investment choice. However, disadvantage factors and threat such as serious competition in Interventional Cardiology Industry should be considered.
The global Interventional Cardiology market is valued at 3 million US$ in 2017 and will reach 4 million US$ by the end of 2025, growing at a CAGR of 3.0% during 2018-2025.
The major manufacturers covered in this report
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
Bard Peripheral Vascular，Inc
OrbusNeich Medical, BV
Siemens Medical Solutions USA, Inc
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
Other Regions (India, Southeast Asia, Central & South America and Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Fractional flow reserve
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
The study objectives of this report are:
To analyze and study the global Interventional Cardiology capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Interventional Cardiology manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Interventional Cardiology are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Interventional Cardiology Manufacturers
Interventional Cardiology Distributors/Traders/Wholesalers
Interventional Cardiology Subcomponent Manufacturers
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Interventional Cardiology market, by end-use.
Detailed analysis and profiles of additional market players.